ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionStandard Life Aberdeen plc
Latest Disclosed Ownership237,839 shares
Latest Disclosed Value $ 53,390,099
Standard Life Aberdeen plc reports 0.58% decrease in ownership of RMD / ResMed Inc.

On April 29, 2026 - Standard Life Aberdeen plc filed a 13F-HR form disclosing ownership of 237,839 shares of ResMed Inc. (MX:RMD) valued at $53,390,099 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 239,236 shares of ResMed Inc.. This represents a change in shares of -0.58% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F RESMED COM 761152107 237,839 -1,397 -0.58 53,390 -7.35 0.0468
2026-01-16 2025-12-31 13F RESMED COM 761152107 239,236 -37,737 -13.62 57,625 -24.12 0.0892
2025-11-07 2025-09-30 13F RESMED COM 761152107 276,973 -19,579 -6.60 75,936 0.07 0.1201
2025-07-24 2025-06-30 13F RESMED COM 761152107 296,552 -113,827 -27.74 75,885 -16.21 0.1291
2025-05-13 2025-03-31 13F RESMED COM 761152107 410,379 42,123 11.44 90,569 7.26 0.1766
2025-01-24 2024-12-31 13F RESMED COM 761152107 368,256 -29,554 -7.43 84,439 -12.30 0.1585
2024-10-25 2024-09-30 13F RESMED COM 761152107 397,810 33,451 9.18 96,284 38.05 0.1765
2024-08-09 2024-06-30 13F RESMED COM 761152107 364,359 6,903 1.93 69,746 -1.47 0.1337
2024-05-09 2024-03-31 13F RESMED COM 761152107 357,456 -89,701 -20.06 70,787 -7.97 0.1388
2024-01-31 2023-12-31 13F RESMED COM 761152107 447,157 -454,328 -50.40 76,920 -42.30 0.1668
2023-11-07 2023-09-30 13F RESMED COM 761152107 901,485 398,302 79.16 133,303 21.24 0.3402
2024-06-20 2023-06-30 13F/A-1 RESMED COM 761152107 503,183 256,980 104.38 109,945 103.92 0.2558
2023-08-04 2023-06-30 13F RESMED COM 761152107 503,183 256,980 109,945 0.2558
2024-06-20 2023-03-31 13F/A-1 RESMED COM 761152107 246,203 19,642 8.67 53,916 14.34 0.1349
2023-04-28 2023-03-31 13F RESMED COM 761152107 246,203 19,642 53,916 0.1349
2024-06-20 2022-12-31 13F/A-1 RESMED COM 761152107 226,561 16,139 7.67 47,154 2.65 0.1282
2023-02-10 2022-12-31 13F RESMED COM 761152107 226,561 16,139 47,154 0.1282
2022-11-10 2022-09-30 13F RESMED COM 761152107 210,422 64,290 43.99 45,936 48.49 0.1368
2022-08-05 2022-06-30 13F RESMED COM 761152107 146,132 48,813 50.16 30,935 29.70 0.0972
2022-05-04 2022-03-31 13F RESMED COM 761152107 97,319 -1,206 -1.22 23,852 -7.06 0.0610
2022-02-10 2021-12-31 13F/A-1 RESMED COM 761152107 98,525 -898 -0.90 25,664 -3.04 0.0564
2022-02-08 2021-12-31 13F RESMED COM 761152107 98,525 -898 25,664 0.0185
2021-11-15 2021-09-30 13F RESMED COM 761152107 99,423 8,978 9.93 26,469 18.71 0.0596
2021-08-10 2021-06-30 13F RESMED COM 761152107 90,445 -6,219 -6.43 22,297 18.87 0.0488
2021-05-06 2021-03-31 13F RESMED COM 761152107 96,664 8,898 10.14 18,757 0.50 0.0426
2021-02-10 2020-12-31 13F RESMED COM 761152107 87,766 -64,277 -42.28 18,664 -28.39 0.0455
2020-10-21 2020-09-30 13F RESMED COM 761152107 152,043 -22,618 -12.95 26,065 -22.28 0.0696
2020-08-10 2020-06-30 13F RESMED COM 761152107 174,661 -19,863 -10.21 33,535 17.04 0.0908
2020-05-13 2020-03-31 13F RESMED COM 761152107 194,524 -6,614 -3.29 28,652 -8.09 0.0910
2020-02-18 2019-12-31 13F RESMED COM 761152107 201,138 -5,221 -2.53 31,175 11.74 0.0753
2019-11-13 2019-09-30 13F RESMED COM 761152107 206,359 -22,869 -9.98 27,900 -0.26 0.0696
2019-08-13 2019-06-30 13F RESMED COM 761152107 229,228 14,323 6.66 27,972 25.18 0.0621
2019-05-14 2019-03-31 13F RESMED COM 761152107 214,905 15,499 7.77 22,346 0.82 0.0484
2019-02-12 2018-12-31 13F RESMED COM 761152107 199,406 34,123 20.65 22,164 16.27 0.0526
2018-11-20 2018-09-30 13F/A-1 RESMED COM 761152107 165,283 14,040 9.28 19,063 21.68 0.0355
2018-11-13 2018-09-30 13F RESMED COM 761152107 165,283 14,040 19,063
2018-08-09 2018-06-30 13F RESMED COM 761152107 151,243 126,002 499.20 15,667 530.46 0.0301
2018-05-15 2018-03-31 13F RESMED COM 761152107 25,241 -456 -1.77 2,485 14.20 0.0049
2018-02-12 2017-12-31 13F RESMED COM 761152107 25,697 462 1.83 2,176 11.99 0.0042
2017-11-14 2017-09-30 13F RESMED COM 761152107 25,235 25,235 1,943 0.0035
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.